NCT02182102View on ClinicalTrials.gov

Dose Escalation of BIBF 1120 Combined With Pemetrexed in Advanced Non Small Cell Lung Cancer

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

May 31, 2010

Conditions
Carcinoma, Non-Small-Cell Lung
Interventions
DRUG

BIBF 1120

DRUG

Pemetrexed

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY